Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Comparative Effectiveness Bill Calls For Private Group To Plan Research

Executive Summary

While getting little exposure in the new Medicare law, comparative effectiveness research is getting full attention in a bill introduced by Sen. Max Baucus, D-Mont., that offers a comprehensive roadmap toward conducting the research and disseminating findings

You may also be interested in...



Baucus Takes “Patient-Centered” Focus For Comparative Effectiveness In Bill

The changes Sen. Max Baucus made in a reintroduced comparative effectiveness bill may be small compared to the 2008 version, but they suggest a different focus that might be a more welcome approach by the pharma industry

Baucus Takes “Patient-Centered” Focus For Comparative Effectiveness In Bill

The changes Sen. Max Baucus made in a reintroduced comparative effectiveness bill may be small compared to the 2008 version, but they suggest a different focus that might be a more welcome approach by the pharma industry

PhRMA, Others Look For Savings In Reduced Drug Interactions

Reducing the instances of adverse events related to drug-drug interactions is among the options to reduce health care spending presented by both the Pharmaceutical Research and Manufacturers of America and the American Medical Association

Related Content

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel